Healthcare · Sep 24, 2026
Growth came from clinics it already had
GUSHENGTANG (2273.HK): The Company Spent HK$360M Buying Its Own Stock in Six Months. Profit Is Up 44%.
Read the analysis →
Where the consensus stops, the research starts.